Getnet M Assefa

#pharmacist, #pharmacologist, PhD student @UQCCR,#Antimicrobial #PK/PD, #HFIM, #popPK, #AMO

[Getnet M Assefa @mgetnet21]

📢 New publication!
✅ Largest #PopulationPK analysis of #tazobactam
✅ Supports dose optimisation in #ARCpatients

Many thanks to @b_fekade, @jasonroberts_pk, and all collaborators.

https://t.co/lDlszmm24f

#Tazobactam #PopulationPK @CRE_RESPOND

[CRE RESPOND @CRE_RESPOND]

📢 Reminder: Registrations are still open for our Dose Optimisation and Life-Support Therapies Seminar on 17 September.

Hear from Dr Marta Ulldemolins, @HaifaLyster, @paulcritpharm, with Prof @jasonroberts_pk as Chair.

📍 Frazer Institute, Herston | 💻 Zoom

Register today: https://t.co/a8HpgzaYbh

#CRERESPOND #CriticalCare #ECMO #AntimicrobialStewardship #PrecisionDosing

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🔥 Just published 🔥 @PharmacoJournal

Focused Update to International Consensus Recommendations for the Use of Prolonged-Infusion Beta-Lactam Antibiotics Among Severely Ill Adult Patients

Led by Lisa Hong 🌟

Endorsed by:
@ACCP @BSACandJAC @IDSAInfo @ESCMID @SCCM @CF_Foundation @SIDPharm

#IDXposts
EnJoy
https://t.co/x16fRPLn2e

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🔥FDA has approved Zaynich (cefepime and zidebactam) for adults with complicated urinary tract infections (cUTIs) caused by designated susceptible microorganisms.🔥 #idxposts
@BradSpellberg @IDstewardship https://t.co/WbXvttg5zB

[CRE RESPOND @CRE_RESPOND]

On this week: CRE RESPOND’s Precision Dosing Seminar!
Chaired by Professor Jason Roberts (@jasonroberts_pk), with sessions on beta‑lactam dosing, S. aureus bacteraemia optimisation, and antibacterial dosing in ECMO.
Featuring A/Prof Erin Barreto (@erin_barreto), Rekha Mangalore, Leon Smareglia & Hafiz Abdul‑Aziz.
Registration is free — we’d love for you to join us: https://t.co/hPc1onCtRp

#CRERESPOND #PrecisionDosing #AntimicrobialStewardship #InfectiousDiseases #MedEd

[CRE RESPOND @CRE_RESPOND]

📣 A quick reminder that our 3‑day Fundamentals of Population Pharmacokinetics workshop is coming up! Whether you’re stepping into PK for the first time or refreshing your understanding, you’ll get guided, practical experience with real datasets and model‑building workflows.

📅 15–17 July 2026
📍 UQ Brisbane City
💲AUD 650

We’ll cover key PK principles, PopPK basics, dataset construction, model development, validation, and Monte Carlo simulations — all in a supportive, beginner‑friendly environment.

🎟️ Registration and details: https://t.co/H5UH58ZkxK

[Bin Lin @Pharm_BinLin]

BLING III is changing clinical practice guidelines!!! Great work👍

[Getnet M Assefa @mgetnet21]

Worth reading!!
https://t.co/lKYBPbeOeZ

[Getnet M Assefa @mgetnet21]

Highly recommended PK workshop!!

[CRE RESPOND @CRE_RESPOND]

📢 New to pharmacokinetics or need a refresher?
Join us for a beginner‑friendly in-person 3‑day workshop: Fundamentals of Population Pharmacokinetics!

📅 15–17 July 2026
📍 UQ Brisbane City, Brisbane CBD

Dive into core PK concepts and learn how to build and validate your own PopPK model.

🔍 Topics include:
• Key PK principles
• Intro to PopPK
• Dataset building
• Model development & validation
• Monte Carlo simulations

Open to students, pharmacists, clinicians, researchers—anyone curious about PK. No prior experience needed.

💲 Cost: AUD 650
🎟️ Limited places, more info and register now: https://t.co/H5UH58ZkxK

[ESCMID @ESCMID]

The AMR Action Subcommittee and Study Group for Artificial intelligence and Digitalisation (ESGAID) recently published a perspective on the implications of using AI in the fight against #AMR. Check it out: https://t.co/xkSAFpVR1D

[Getnet M Assefa @mgetnet21]

Worth attending!

[International Society of Antimicrobial Chemotherap @ISAC_world]

🌟 Meet the Speaker 🌟
Join Session 1 of our Critical Care Infectious Diseases – Hot Topics & Trends webinar series
🗓 24 Nov 2025

Prof. Jason Roberts, a global leader in antimicrobial dosing, directs UQ Clinical Research, with 650+ publications
https://t.co/UKi5pJLFY6
#WAAW2025

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Super interesting!
🆕💫Keeping the horse *with the cart: are we underdosing tazobactam even when using continuous-infusion ceftolozane/tazobactam for effectively preventing resistance development by ESBL-producing Enterobacterales #IDXposts
https://t.co/dwvwRA1xP6

[CRE RESPOND @CRE_RESPOND]

🙌We are proud to introduce CRE RESPOND's final seminar of the year as part of the Education Program 2025!🙌

We're thrilled to announce that the UTI Guidelines: Clinical practice guidelines on prevention and management of Urinary Tract Infections (UTIs) seminar will take place on:

📅Thursday 20th November, 12pm-1pm AEST

At the:

📍Auditorium of the UQ Centre for Clinical Research

Our speakers include guideline authors and committee members who will present on the newly published clinical practice guidelines for UTI's📖

Register here: https://t.co/n01CygKvsj

#CRERESPOND #UQCCR #UTI #Guidelines #Infections #Prevention #Management #UrinaryTract

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Super interesting!
🆕💫Comparative in vitro activity of ceftazidime-avibactam plus aztreonam and the fixed combination aztreonam/avibactam against multidrug-resistant Pseudomonas aeruginosa #idxposts
The punch effect! https://t.co/hH9pqM6dTy

[Patrick Harris @padstamundo]

New RCT from @UQMedicine Cefiderocol versus standard therapy for healthcare-associated Gram-negative BSI @UQ_GAMECHANGER @UQ_News >500 patients in 6 countries with high rates of MDR; 25% carb-R; Non-inferior but not superior for 14d mortality @TheLancetInfDis @davidantibiotic

[CRE RESPOND @CRE_RESPOND]

🤩The third instalment of the CRE RESPOND quarterly newsletter will be sent out tomorrow!🤩

📣 Our newsletter lets you stay informed on our talented and dedicated team of researchers and their current projects and publications, as well as our visitors who come from all over the world to work with us.

If you want to learn all about the team and the amazing work they do, our newsletter is the best place to find all that information in one go!

Subscribe here: https://t.co/xY35aL5lbw

In advance of its release tomorrow, here's a little sneak peak of what you can expect... 🤫

[Getnet M Assefa @mgetnet21]

Honoured to receive the HDR Award Winner recognition at the Herston Health Precinct Symposium 2025.
I am grateful to my supervisors, @b_fekade and @jasonroberts_pk, for their invaluable support. #HHPS2025, @CRE_RESPOND, #UQCCR, @UQMedicine, @UQ_News

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

💥 BIG problems need BIG solutions

Drug resistance is putting lives at risk worldwide.

That’s why we’re launching #ThisIsBig—a bold campaign calling for greater investment and collaboration to develop new antibiotics and expand access to treatment 🚀

📢 Share the video. Join the movement.

🔗 https://t.co/e4TD2klXRc

[Getnet M Assefa @mgetnet21]

Our article: https://t.co/KrOPQnlLQX… has been selected for inclusion in the Best of Journal of Antimicrobial Chemotherapy 2024.
@b_fekade @jasonroberts_pk @CRE_RESPOND #UQCCR @UQMedicine @UQ_News
https://t.co/UjO3A8US6g

[Pharmacy To Dose: The Critical Care Podcast @PharmacyToDose]

SO excited to officially announce the 2024 Pharmacy to Dose Award winners! 🎉 🍾

Research article of the year: Jason Roberts @jasonroberts_pk

Non-research article of the year : Mojdeh Heavner @HeavnerPharmD

Preceptor of the Year: Grace Benanti

Mentor of the Year: Brian Gilbert @GilbertPharmD

Conference Speaker of the Year: Gretchen Sacha @gretchensacha

Unsung Hero award: Caitlin Brown @CBthePHARMD

Tag Team Tandem Award: Kat Spezzano and Christian Kressin @KatSpazPharmD @CKressinPharmD

People’s Choice Award: Andy Webb @AJWPharm

Black Cloud award: Haley Peters

MVP: Anthony Hawkins @iamahawkins

Living Legend award: Nicole Acquisto

Thank you so much everyone for voting!! Full awards episode coming very soon 👀 👏🏻